From Industry To Non-Profit And Back
Rebecca Tan | February 11, 2016 | Editorials
Tachi Yamada, chief medical & scientific officer of Takeda Pharmaceuticals, shares his journey from academia to industry, non-profit organizations and back, and why Asia is now the place to be.
MORE NEWS FROM Japan
7 Must-Read Stories In January 2016
In the Lab
Placental Microvilli ‘Grow’ With The Flow
Schizophrenia In The Media: What A Difference A Name Makes
A study has assessed the impact of Japan changing the term for schizophrenia in 2002 from “seishin-bunretsu-byō” (mind-split disease) to “tōgō-shitchō-shō” (integration disorder).